MHO Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance LMRI Q1 2026 Earnings Strong EPS Beat Masks Revenue Concerns and Stock Decline KOS Q1 2026 Earnings EPS Miss Weighs on Shares as Operating Environment Challenges Persist Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development ACGLO Q1 2026 Earnings EPS Falls Short of Estimates Amidst Challenging Market Conditions STE Q1 2026 Earnings EPS Miss Amidst Operational Headwinds CMCSA Q1 2026 Earnings EPS Beats Estimates Amid Mixed Signals SAIL Q1 2026 Earnings Slight EPS Miss Masks Resilient Demand Stock Edges Up LUCD Q1 2026 Earnings Wider Loss Than Expected as Company Navigates Operational Challenges DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 authID Q1 2026 Earnings Narrowing Operating Loss Despite PreRevenue Status SM Q1 2026 Earnings Robust Earnings Beat Driven by Operational Efficiency Cytokinetics Q1 2026 Earnings Small EPS Beat Amid Continued RD Focus